Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (82)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Ferrell, R. E.
Right arrow Articles by Finegold, D. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ferrell, R. E.
Right arrow Articles by Finegold, D. N.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, Vol 7, 2073-2078, Copyright © 1998 by Oxford University Press


ARTICLES

Hereditary lymphedema: evidence for linkage and genetic heterogeneity

RE Ferrell, KL Levinson, JH Esman, MA Kimak, EC Lawrence, MM Barmada and DN Finegold
Departments of Human Genetics, Physical Medicine and Rehabilitation and Pediatrics, University of Pittsburgh, 130 DeSoto Street, Pittsburgh, PA 15261, USA.

Hereditary or primary lymphedema is a developmental disorder of the lymphatic system which leads to a disabling and disfiguring swelling of the extremities. Hereditary lymphedema generally shows an autosomal dominant pattern of inheritance with reduced penetrance, variable expression and variable age at onset. Three multigeneration families demonstrating the phenotype of hereditary lymphedema segregating as an autosomal dominant trait with incomplete penetrance were genotyped for 366 autosomal markers. Linkage analysis yielded a two-point LOD score of 6.1 at straight theta = 0. 0 for marker D5S1354 and a maximum multipoint LOD score of 8.8 at marker D5S1354 located at chromosome 5q34-q35. Linkage analysis in two additional families using markers from the linked region showed one family consistent for linkage to distal chromosome 5. In the second family, linkage to 5q was excluded for all markers in the region with LOD scores Z < -2.0. The vascular endothelial growth factor C receptor ( FLT4 ) was mapped to the linked region, and partial sequence analysis identified a G-->A transition at nucleotide position 3360 of the FLT4 cDNA, predicting a leucine for proline substitution at residue 1126 of the mature receptor in one nuclear family. This study localizes a gene for primary lymphedema to distal chromosome 5q, identifies a plausible candidate gene in the linked region, and provides evidence for a second, unlinked locus for primary lymphedema.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
VASC ENDOVASCULAR SURGHome page
B. B. Lee, Y. W. Kim, J. M. Seo, J. H. Hwang, Y. S. Do, D. I. Kim, H. S. Byun, S. K. Lee, S. H. Huh, and W. S. Hyun
Current Concepts in Lymphatic Malformation
Vascular and Endovascular Surgery, January 1, 2005; 39(1): 67 - 81.
[Abstract] [PDF]


Home page
J. Med. Genet.Home page
A L Evans, R Bell, G Brice, P Comeglio, C Lipede, S Jeffery, P Mortimer, M Sarfarazi, and A H Child
Identification of eight novel VEGFR-3 mutations in families with primary congenital lymphoedema
J. Med. Genet., September 1, 2003; 40(9): 697 - 703.
[Full Text] [PDF]


Home page
Physiol. Rev.Home page
L. Jussila and K. Alitalo
Vascular Growth Factors and Lymphangiogenesis
Physiol Rev, July 1, 2002; 82(3): 673 - 700.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
G Brice, S Mansour, R Bell, J R O Collin, A H Child, A F Brady, M Sarfarazi, K G Burnand, S Jeffery, P Mortimer, et al.
Analysis of the phenotypic abnormalities in lymphoedema-distichiasis syndrome in 74 patients with FOXC2 mutations or linkage to 16q24
J. Med. Genet., July 1, 2002; 39(7): 478 - 483.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
G. Oliver and M. Detmar
The rediscovery of the lymphatic system: old and new insights into the development and biological function of the lymphatic vasculature
Genes & Dev., April 1, 2002; 16(7): 773 - 783.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. F. Wang, X.-F. Zhang, and J. E. Groopman
Stimulation of beta 1 Integrin Induces Tyrosine Phosphorylation of Vascular Endothelial Growth Factor Receptor-3 and Modulates Cell Migration
J. Biol. Chem., November 2, 2001; 276(45): 41950 - 41957.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. S. Bray, J. Krushkal, L. Li, R. Ferrell, S. Kardia, C. F. Sing, S. T. Turner, and E. Boerwinkle
Positional Genomic Analysis Identifies the {beta}2-Adrenergic Receptor Gene as a Susceptibility Locus for Human Hypertension
Circulation, June 27, 2000; 101(25): 2877 - 2882.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Veikkola, M. Karkkainen, L. Claesson-Welsh, and K. Alitalo
Regulation of Angiogenesis via Vascular Endothelial Growth Factor Receptors
Cancer Res., January 1, 2000; 60(2): 203 - 212.
[Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. J. Karkkainen, A. Saaristo, L. Jussila, K. A. Karila, E. C. Lawrence, K. Pajusola, H. Bueler, A. Eichmann, R. Kauppinen, M. I. Kettunen, et al.
A model for gene therapy of human hereditary lymphedema
PNAS, October 23, 2001; 98(22): 12677 - 12682.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.